For citations:
Beketova T.V., Levina N.O., Uskova Yu.A., Rozanova I.V., Dubinskaia M.V., Evdokimova S.A., Babak V.V., Beketova M.F., Devyatkin A.V. Pre-exposure prophylaxis of COVID-19 with tixagevimab/cilgavimab (Evusheld) in 63 rituximab-treated patients with ANCA-associated systemic vasculitis: two-year follow-up results. Rheumatology Science and Practice. 2024;62(5):465-473. (In Russ.) https://doi.org/10.47360/1995-4484-2024-465-473